Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
FCPM III SERVICES B.V. (CIK 2013410) reported $750.4M across 11 reported positions in its SEC 13F filing for 2026-06-30. Largest positions: NAMS ($287.7M, 38.34%), MPLT ($115.6M, 15.41%), DYN ($85.5M, 11.39%), VOR ($75.8M, 10.10%), DMRA ($63.5M, 8.46%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | NAMS | NEWAMSTERDAM PHARMA COMPANY | $287.7M | 38.34% | 8.5M | Trimmed |
| 2 | MPLT | MAPLIGHT THERAPEUTICS INC | $115.6M | 15.41% | 3.2M | Hold |
| 3 | DYN | DYNE THERAPEUTICS INC | $85.5M | 11.39% | 3.8M | Trimmed |
| 4 | VOR | VOR BIOPHARMA INC | $75.8M | 10.10% | 4.1M | Hold |
| 5 | DMRA | DAMORA THERAPEUTICS INC | $63.5M | 8.46% | 2.4M | Hold |
| 6 | REPL | REPLIMUNE GROUP INC | $31.1M | 4.14% | 2.8M | Hold |
| 7 | CBIO | CRESCENT BIOPHARMA INC. | $30.2M | 4.02% | 1.7M | Hold |
| 8 | AURA | AURA BIOSCIENCES INC | $28.8M | 3.84% | 4.1M | New |
| 9 | ENGN | ENGENE HOLDINGS INC | $16.7M | 2.22% | 9.6M | Hold |
| 10 | BCYC | BICYCLE THERAPEUTICS PLC | $14.7M | 1.96% | 3.5M | Hold |
| 11 | ENGNW | ENGENE HOLDINGS INC | $834,376 | 0.11% | 2.9M | Hold |
Source: SEC Form 13F filings · as of 2026-06-30